Vanderbilt University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Clinical Trials
518
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (392 trials with phase data)• Click on a phase to view related trials
Project PAIR: Parent-implemented Articulation Intervention With Recast
- Conditions
- Hearing Impaired Children
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 10
- Registration Number
- NCT06936696
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Sentence Shaping - DHH
- Conditions
- Hearing Loss, Bilateral
- First Posted Date
- 2025-03-05
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT06860022
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Evaluation of MBCT Implemented in Vietnamese Buddhist Pagoda
- Conditions
- Depressive SymptomsQuality of Life
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 160
- Registration Number
- NCT06598579
- Locations
- 🇻🇳
VNU University of Education, Hanoi, Vietnam
A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
- Conditions
- PreventionControl
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 360
- Registration Number
- NCT06526052
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Northwestern University, Evanston, Illinois, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes
- Conditions
- PreDiabetesDiet, HealthyNutritional and Metabolic Diseases
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT06482944
- Locations
- 🇺🇸
Vanderbilt University School of Nursing, Nashville, Tennessee, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 104
- Next
News
UroMems Receives FDA and ANSM Clearance for Pivotal Trial of Smart Artificial Urinary Sphincter
UroMems received investigational device exemption approval from the FDA and French ANSM to begin the SOPHIA2 pivotal trial of its UroActive smart implant for treating male stress urinary incontinence.
Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia
Neumora Therapeutics has initiated a Phase 1 single-ascending dose/multiple-ascending dose study of NMRA-861, a highly potent and selective positive allosteric modulator of the M4 muscarinic receptor for schizophrenia treatment.
Abvance Therapeutics Presents First Human Data on Fixed-Ratio Insulin-Glucagon Combination for Type 1 Diabetes
Abvance Therapeutics presented the first human clinical data evaluating fixed-ratio co-administration of insulin and glucagon at mealtime in Type 1 diabetes patients at the 85th ADA Scientific Sessions.
Nanobody Platform Enhances Cancer Immunotherapy Through Albumin Hitchhiking and STING Activation
Vanderbilt researchers developed albumin-hitchhiking nanobodies that extend circulation time from 5 minutes to 55 hours and achieve 11% injected dose per gram tumor accumulation.
VU319 Shows Promise in Phase 1 Trial for Alzheimer's Disease
VU319, an M1 positive allosteric modulator, has demonstrated encouraging results in a Phase 1 clinical trial for Alzheimer's disease and other neurodegenerative conditions.